cGMP-independent mechanism of airway smooth muscle relaxation induced by S-nitrosoglutathione

American Journal of Physiology - Cell Physiology

Volumn 275, Issue 2 44-2, 1998, Pages

  Perkins, William J ^a   Pabelick, Christina ^a   Warner, David O ^a   Jones, Keith A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Canine lung; Canine trachea; DL dithiothreitol; Guanosine 3',5' cyclic monophosphate; Nitric oxide; Sulfhydryl reagents

Indexed keywords

CYCLIC GMP; DITHIOTHREITOL; NITRIC OXIDE; S NITROSOGLUTATHIONE;

AIRWAY PRESSURE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DOG; ENZYME ACTIVITY; ENZYME INHIBITION; HYPOTHESIS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; TRACHEA MUCOSA;

ANIMALIA; CANIS FAMILIARIS;

EID: 0031867631     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1998.275.2.c468     Document Type: Article

References (34)

1. 2+ release channel from oxidation induced activation. J. Biol. Chem. 272: 25462-25467, 1997.
2. Bennett, B. M., L. D. Hayward, and F. Murad. Effects of the D and L stereoisomers of isosorbide dinitrate on relaxation and cyclic GMP accumulation in rat aorta and comparison to glyceryl trinitrate. J. Appl. Cardiol. 1: 203-209, 1986.
3. Brooker, G., J. F. Harper, W. L. Terasaki, and R. D. Moylan. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv. Cyclic Nucleotide Res. 10: 1-33, 1979.
4. Chandra, T. S., N. Nath, H. Suzuki, and J. C. Seidel. Modification of thiols of gizzard myosin alters ATPase activity, stability of myosin filaments, and the 6-10 S conformational transition. J. Biol. Chem. 260: 202-207, 1985.
5. Clancy, R. M., D. Levartovsky, J. Leszczynska-Piziak, J. Yegudin, and S. B. Abramson. Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary. Proc. Natl. Acad. Sci. USA 91: 3680-3684, 1994.
6. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J. Biol. Chem. 264: 1146-1155, 1989.
7. + as the effective reagent in nitric oxide formation from S-nitrosothiols (RSNO). J. Chem. Soc.-Perkin Trans II: 481-487, 1996.
8. Gopalakrishna, R., Z. H. Chen, and U. Gundimeda. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J. Biol. Chem. 268: 27180-27185, 1993.
9. Hirasaki, A., K. A. Jones, W. J. Perkins, and D. O. Warner. Use of nitric oxide nucleophile adducts as biological sources of nitric oxide: effects on airway smooth muscle. J. Pharmacol. Exp. Ther. 278: 1269-1275, 1996.
10. Ignarro, L. J., J. N. Degnan, W. H. Baricos, P. J. Kadowitz, and M. S. Wolin. Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim. Biophys. Acta 718: 49-59, 1982.
11. Jansen, A., J. Drazen, J. A. Osborne, R. Brown, J. Loscalzo, and J. S. Stamler. The relaxant properties in guinea pig airways of S-nitrosothiols. J. Pharmacol. Exp. Ther. 261: 154-160, 1992.
12. 2+ in airway smooth muscle independently of cyclic nucleotides. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L166-L172, 1995.
13. Jones, K. A., R. R. Lorenz, D. O. Warner, Z. S. Katusic, and G. C. Sieck. Changes in cytosolic cGMP and calcium in airway smooth muscle relaxed by 3-morpholinosydnonimine. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L9-L16, 1994.
14. Katsuki, S., W. Arnold, C. K. Mittal, and F. Murad. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cyclic Nucleotide Res. 3: 23-35, 1977.
15. Kowaluk, E. A., and H. L. Fung. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J. Pharmacol. Exp. Ther. 255: 1256-1264, 1990.
16. Lei, S. Z., Z. H. Pan, S. K. Aggarwal, H. S. Chen, J. Hartman, N. J. Sucher, and S. A. Lipton. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8: 1087-1099, 1992.
17. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
18. Mayer, B., A. Schrammel, P. Klatt, D. Koesling, and K. Schmidt. Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase. Dependence on glutathione and possible role of S-nitrosation. J. Biol. Chem. 270: 17355-17360, 1995.
19. Meddings, J. B., R. B. Scott, and G. H. Fick. Analysis and comparison of sigmoidal curves: application to dose-response data. Am. J. Physiol. 257 (Gastrointest. Liver Physiol. 20): G982-G989, 1989.
20. Meszaros, L. G., I. Minarovic, and A. Zahradnikova. Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide. FEBS Lett. 380: 49-52, 1996.
21. Moncada, S., R. M. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
22. Moro, M. A., R. J. Russell, S. Cellek, I. Lizasoain, Y. C. Su, V. M. Darleyusmar, M. W. Radomski, and S. Moncada. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. USA 93: 1480-1485, 1996.
23. Murad, F. Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 78: 1-5, 1986.
24. Myers, P. R., R. L. Minor, Jr., R. Guerra, Jr., J. N. Bates, and D. G. Harrison. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345: 161-163, 1990.
25. Olson, N. J., R. B. Pearson, D. S. Needleman, M. Y. Hurwitz, B. E. Kemp, and A. R. Means. Regulatory and structural motifs of chicken gizzard myosin light chain kinase. Proc. Natl. Acad. Sci. USA 87: 2284-2288, 1990.
26. Perkins, W. J., Y. S. Han, and G. C. Sieck. Skeletal muscle force and actomyosin ATPase activity reduced by nitric oxide donor. J. Appl. Physiol. 83: 1326-1332, 1997.
27. Singh, R. J., N. Hogg, J. Joseph, and B. Kalyanaraman. Mechanism of nitric oxide release from S-nitrosothiols. J. Biol. Chem. 271: 18596-18603, 1996.
28. Somlyo, A. P., and A. V. Somlyo. Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994.
29. Stamler, J. S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78: 931-936, 1994.
30. Stamler, J. S., O. Jaraki, J. Osborne, D. I. Simon, J. Keaney, J. Vita, D. Singel, C. R. Valeri, and J. Loscalzo. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA 89: 7674-7677, 1992.
31. Stamler, J. S., D. J. Singel, and J. Loscalzo. Biochemistry of nitric oxide and its redox-activated forms. Science 258: 1898-1902, 1992.
32. Stuart-Smith, K., T. C. Bynoe, K. S. Lindeman, and C. A. Hirshman. Differential effects of nitrovasodilators and nitric oxide on porcine tracheal and bronchial muscle in vitro. J. Appl. Physiol. 77: 1142-1147, 1994.
33. Wolosker, H., R. Panizzutti, and S. Engelender. Inhibition of creatine kinase by S-nitrosoglutathione. FEBS Lett. 392: 274-276, 1996.
34. Zhou, H. L., and T. J. Torphy. Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators. J. Pharmacol. Exp. Ther. 258: 972-978, 1991.